Related Experiment Video
Updated: Apr 28, 2026
08:03
A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
9.0K
Comparative metabolomics and structural characterizations illuminate colibactin pathway-dependent small molecules
Maria I Vizcaino1, Philipp Engel, Eric Trautman
1Department of Chemistry, Yale University , New Haven, Connecticut 06520, United States.
Journal of the American Chemical Society
|June 17, 2014
Summary
Researchers identified small molecules produced by the colibactin gene cluster in Escherichia coli. These molecules have potential probiotic and carcinogenic activities, offering insights into gut health and disease.
Area of Science:
- Microbiology
- Metabolomics
- Molecular Biology
Background:
- The colibactin gene cluster in Escherichia coli is linked to gut persistence, probiotic effects, and cancer.
- Functional small molecules produced by this pathway remain largely uncharacterized.
Purpose of the Study:
- To identify and characterize small molecules dependent on the colibactin pathway.
- To explore the biological activities of these novel compounds.
Main Methods:
- Comparative metabolomics and targeted structural network analyses were employed.
- Analysis was performed on E. coli strains IHE3034 and Nissle 1917.
Main Results:
- Ten colibactin pathway-dependent small molecules were identified, with proposed structures.
- A network was established to guide further elucidation of pathway-encoded molecules.
- In vitro bacterial growth inhibitory and mammalian CNS receptor antagonist activities were observed.
Conclusions:
- The study provides a catalog of novel small molecules associated with the colibactin pathway.
- These findings offer a roadmap for understanding the functional roles of colibactin-related metabolites.
- The identified molecules exhibit potential for therapeutic and mechanistic investigations.
